All as the announcement today said was that the profit outlook may need to be written down.
Otherwise here is the financial year 2015 results:
FY2015 Financial highlights – Australia & 2H 2015 strong
Total sales up 7.5% to $1.32bn; comp sales +1%
Strong Australian performance offset by challenging NZ market
Gross profit +6.1%; Australia gross profit +9.8% with 24.9% GM
EBITDA1 $79.8m (+7.3%) at margin of 6%
EBITDA in Australia $75.7m (+21.9%) at margin of 6.1%
NPAT1 $43.4m (+3.1%) with 2H2015 NPAT growth of 6.3%
5cps final dividend (fully
- Forums
- ASX - By Stock
- DSH
- Fair Price
Fair Price, page-2
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DSH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online